[Effect of 17alpha-hydroxyprogesterone caproate and of 6alpha-methyl-17alpha-hydroxyprogesterone acetate on hexosekinase, phosphofructose kinase and pyruvate kinase of the human myometrium].
D000328:Adult; D002208:Caproates / Q000494:pharmacology*; D005260:Female; D006593:Hexokinase / Q000378:metabolism*; D006801:Humans; D006908:Hydroxyprogesterones / Q000494:pharmacology*; D008875:Middle Aged; D010732:Phosphofructokinase-1 / Q000378:metabolism*; D011770:Pyruvate Kinase / Q000378:metabolism*; D014599:Uterus / Q000187:drug effects* / Q000201:enzymology
D002208:Caproates; D006908:Hydroxyprogesterones; D006593:Hexokinase; D010732:Phosphofructokinase-1; D011770:Pyruvate Kinase
Effecto del capronato di 17alpha-idrossiprogesterone e dell'acetato di 6alpha-metil-17alpha-idrossiprogesterone su esosocinasi, fosfofruttosocinasi e piruvatocinasi del miometrio umano.